Organigram Global (OGI) Income towards Parent Company (2018 - 2026)

Organigram Global (OGI) posted quarterly Income towards Parent Company of $13.9 million for Q1 2026, down 52.94% year-on-year from $29.5 million in Q1 2025, and up 176.71% on a QoQ basis from $5.0 million in Q4 2025.

Organigram Global (OGI) Income towards Parent Company (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Income towards Parent Company for 7 consecutive years, with $13.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Income towards Parent Company fell 52.94% year-over-year to $13.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.4 million (up 96.48% YoY) and the FY2025 annual result came in at $4.5 million, changed N/A from the prior year.
  • Income towards Parent Company climbed to $13.9 million in Q1 2026 per OGI's latest filing, from $5.0 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for OGI reached as high as $29.5 million in Q1 2025 and fell as low as -$4.9 million in Q4 2024.
  • A 3-year average of $10.9 million and a median of $9.5 million in 2025 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2025 — Income towards Parent Company surged 203.1% — and 2026, when it slumped 52.94%.
  • Year by year, Income towards Parent Company stood at -$4.9 million in 2024, then soared by 203.1% to $5.0 million in 2025, then jumped by 176.71% to $13.9 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $13.9 million, $5.0 million, and $29.5 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Organigram Global 121.15 Mn 154.23 Mn 28.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.89 Mn
Dec 31, 2025 5.02 Mn
Mar 31, 2025 29.51 Mn
Dec 31, 2024 -4.87 Mn
May 31, 2021 -104.73 Mn
Feb 28, 2021 100.73 Mn
Nov 30, 2020 -34.34 Mn
Aug 31, 2020 -170.07 Mn
May 31, 2020 -65.51 Mn
Feb 29, 2020 -6.83 Mn
Nov 25, 2019 15.25 Mn
May 31, 2019 -7.05 Mn
Nov 30, 2018 -38,000.00
May 31, 2018 -1.27 Mn